Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Daniel, Peter Prof. Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (2) Pezzutto, Antonio Prof. Dr. (5) Siffrin, Volker (1) Uckert, Wolfgang Prof. Dr. (6) Willimsky, Gerald Dr. (7) (-) Blankenstein, Thomas Prof. Dr. (24) (-) Kammertöns, Thomas Dr. (7) (-) Kopp, Joachim Dr. (2) Advanced Light Microscopy (1) Biologie maligner Lymphome (11) Immunregulation und Krebs (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (10) (-) Molekulare Immunologie und Gentherapie (27) Neuroimmunologie-Labor (1) Proteom Dynamik (1) RNA Biologie und Posttranscriptionale Regulation (1) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (4) Translationale Tumorimmunologie (2) Zellzustände und ihre Funktionsweisen (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (3) (-) 2000 (10) 2001 (5) 2002 (5) 2003 (9) 2004 (9) (-) 2005 (10) 2006 (1) 2007 (6) 2008 (5) 2009 (3) 2010 (7) 2011 (5) 2012 (6) 2013 (11) (-) 2014 (3) (-) 2015 (4) 2016 (4) 2017 (6) 2018 (5) 2019 (7) 2020 (3) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 27 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Kammertöns, Thomas Dr.Kopp, Joachim Dr.Molekulare Immunologie und Gentherapie 2000200520142015 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. September 2014 / Eur J Immunol Misinitiation of intrathymic MART-1 transcription and biased TCR usage explain the high frequency of MART-1-specific T cells S. Pinto D. Sommermeyer C. Michel S. Wilde D. Schendel W. Uckert T. Blankenstein B. Kyewski 15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann 01. Dezember 2014 / Canc Res Efficacy of CAR T-cell therapy in large tumors relies upon stromal targeting by IFNγ A. Textor J.J. Listopad L.L. Wührmann C. Perez A. Kruschinski M. Chmielewski H. Abken T. Blankenstein J. Charo 15. Juli 2014 / Int J Cancer Permissive expansion and homing of adoptively transferred T cells in tumor-bearing hosts C. Perez A. Jukica J.J. Listopad K. Anders A.A. Kühl C. Loddenkemper T. Blankenstein J. Charo 01. Januar 2005 / Int J Cancer Tumor-induced antibodies resemble the response to tissue damage S. Preiss T. Kammertoens C. Lampert G. Willimsky T. Blankenstein 01. Januar 2005 / Curr Opin Immunol The role of tumor stroma in the interaction between tumor and immune system T. Blankenstein 01. Januar 2005 / Clin Cancer Res Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs B. Frankenberger H. Pohla E. Noessner G. Willimsky B. Papier A. Pezzutto J. Kopp R. Oberneder T. Blankenstein D.J. Schendel 01. Januar 2005 / Int J Cancer Necrotic death but not irradiation abolishes costimulation of T-cell effector functions and survival by CD80-expressing tumor cells L. Staerck C. Scholz T. Blankenstein B. Doerken P.T. Daniel 01. Januar 2005 / Canc Res CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells T. Kammertoens R. Willebrand B. Erdmann L. Li Y. Li B. Engels W. Uckert T. Blankenstein 01. Januar 2005 / Trends Mol Med Immunotherapy: target the stroma to hit the tumor T. Kammertoens T. Schueler T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
01. September 2014 / Eur J Immunol Misinitiation of intrathymic MART-1 transcription and biased TCR usage explain the high frequency of MART-1-specific T cells S. Pinto D. Sommermeyer C. Michel S. Wilde D. Schendel W. Uckert T. Blankenstein B. Kyewski
15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann
01. Dezember 2014 / Canc Res Efficacy of CAR T-cell therapy in large tumors relies upon stromal targeting by IFNγ A. Textor J.J. Listopad L.L. Wührmann C. Perez A. Kruschinski M. Chmielewski H. Abken T. Blankenstein J. Charo
15. Juli 2014 / Int J Cancer Permissive expansion and homing of adoptively transferred T cells in tumor-bearing hosts C. Perez A. Jukica J.J. Listopad K. Anders A.A. Kühl C. Loddenkemper T. Blankenstein J. Charo
01. Januar 2005 / Int J Cancer Tumor-induced antibodies resemble the response to tissue damage S. Preiss T. Kammertoens C. Lampert G. Willimsky T. Blankenstein
01. Januar 2005 / Curr Opin Immunol The role of tumor stroma in the interaction between tumor and immune system T. Blankenstein
01. Januar 2005 / Clin Cancer Res Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs B. Frankenberger H. Pohla E. Noessner G. Willimsky B. Papier A. Pezzutto J. Kopp R. Oberneder T. Blankenstein D.J. Schendel
01. Januar 2005 / Int J Cancer Necrotic death but not irradiation abolishes costimulation of T-cell effector functions and survival by CD80-expressing tumor cells L. Staerck C. Scholz T. Blankenstein B. Doerken P.T. Daniel
01. Januar 2005 / Canc Res CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells T. Kammertoens R. Willebrand B. Erdmann L. Li Y. Li B. Engels W. Uckert T. Blankenstein
01. Januar 2005 / Trends Mol Med Immunotherapy: target the stroma to hit the tumor T. Kammertoens T. Schueler T. Blankenstein